Deactivation of macrophages with interleukin-4 is the key to the isolation of Tropheryma whippelii

Journal of Infectious Diseases

Volumn 176, Issue 3, 1997, Pages 672-677

  Schoedon, Gabriele ^b   Goldenberger, Daniel ^b   Forrer, Regula ^b   Gunz, Anja ^b   Dutly, Fabrizio ^b   Höchli, Mathias ^b   Altwegg, Martin ^b   Schaffner, Andreas ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; INTERLEUKIN 10; INTERLEUKIN 4;

ARTICLE; BACTERIUM ISOLATION; CASE REPORT; ELECTRON MICROSCOPY; ENDOCARDITIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; INTESTINE BIOPSY; INTESTINE LIPODYSTROPHY; MACROPHAGE ACTIVATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; SPECIES DIFFERENTIATION; TROPHERYMA WHIPPELII;

EID: 0030752985     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514089     Document Type: Article

References (16)

1. Dobbins WO. Whipple's disease. In: Dobbins WO, ed. Whipple's disease. Springfield, IL: CC Thomas, 1987:1-227.
2. Cohen AS, Schimmel EM, Holt PR, Isselbacher KJ. Ultrastructural abnormalities in Whipple's disease. Proc Soc Exp Biol Med 1960;105:411-4.
3. Wilson KH, Blitchington R, Frothingham R, Wilson JA. Phylogeny of the Whipple's-disease-associated bacterium. Lancet 1991;338:474-5.
4. Relman, DA, Schmidt TM, MacDermott RP, Falkow S. Identification of the uncultured bacillus of Whipple's disease. N Engl J Med 1992;327: 293-301.
5. Sieracki JC. Whipple's disease: observation of systemic involvement. Arch Pathol 1958;66:464-7.
6. Dobbins WO. Is there an immune deficit in Whipple's disease? Dig Dis Sci 1981;26:247-52.
7. Bjerknes R, Laerum OD, Odegaard S. Impaired bacterial degradation by monocytes and macrophages from a patient with Whipple's disease. Gastroenterology 1985;89:1139-46.
8. Schaffner A, Schaffner T. Glucocorticoid-induced impairment of macrophage antimicrobial activity: mechanisms and dependence on the state of activation. Rev Infect Dis 1987;9(suppl):S620-9.
9. Schaffner A, Rellstab P. Gamma-interferon restores listericidal activity and concurrently enhances release of reactive oxygen metabolites in dexamethasone-treated human monocytes. J Clin Invest 1988;82:913-9.
10. Blauer F, Groscurth P, Schneemann M, Schoedon G, Schaffner A. Modulation of the antilisterial activity of human macrophages by activating and deactivating cytokines. J Interferon Cytokine Res 1995;15:105-14.
11. Meier-Osusky I, Schoedon G, Blauer F, Schneemann M, Schaffner A. Comparison of the antimicrobial activity of deactivated human macrophages challenged with Aspergillus fumigatus and Listeria monocytogenes. J Infect Dis 1996;174:651-4.
12. Altwegg M, Fleisch-Marx A, Goldenberger D, Hailemariam S, Schaffner A, Kissling R. Spondylodiscitis caused by Tropheryma whippelii. Schweiz Med Wochenschr 1996;126:1495-9.
13. Meier-Willersen HJ, Maiwald M, von Herbay A. Morbus Whipple in Assoziation mit opportunistischen Infektionen. Dtsch Med Wochenschr 1993;118:854-60.
14. Silva MT, Macedo PM, Moura-Nunes JF. Ultrastructure of bacilli and the bacillary origin of the macrophagic inclusions in Whipple's disease. J Gen Microbiol 1985;131:1001-13.
15. Nakane A, Nishikawa S, Sasaki S, et al. Endogenous interleukin-4, but not interleukin-10, is involved in suppression of host resistance against Listeria monocylogenes infection in interferon-depleted mice. Infect Immun 1996;64:1252-8.
16. Leal LM, Moss DW, Kühn R, Muller W, Liew FY. Interleukin-4 transgenic mice of resistant background are susceptible to Leishmania major infection. Eur J Immunol 1993;23:566-9.